Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2010
03/11/2010US20100063040 Sulfonamide Derivative Having PGD2 Receptor Antagonistic Activity
03/11/2010US20100063022 Novel compounds as cannabinoid receptor ligands
03/11/2010US20100063012 Compositions and methods for the treatment of inflammatory diseases
03/11/2010US20100062976 Synthesis of Cyclosporin Analogs
03/11/2010US20100062968 Novel strategies for delivery of active agents using micelles and particles
03/11/2010US20100062074 Allergen inactivating agent
03/11/2010US20100062071 Particle Formulations and Uses Thereof
03/11/2010US20100062027 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
03/11/2010US20100062026 Poly tlr antagonist
03/11/2010US20100062025 Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine
03/11/2010US20100062022 Immunogenic proteins of burkholderia pseudomallei and uses thereof
03/11/2010US20100062021 Vaccination for lawsonia intracellularis
03/11/2010US20100062019 New vaccine formulations
03/11/2010US20100062016 Microorganisms for therapy
03/11/2010US20100062010 Novel peptide compound
03/11/2010US20100061992 Therapeutic uses of tim-3 modulators
03/11/2010US20100061986 Chronic Rejection Inhibitor
03/11/2010US20100061985 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
03/11/2010US20100061965 Respiratory syncytial virus renders dendritic cells tolerogenic
03/11/2010CA2736187A1 Novel compositions and adjuvants
03/11/2010CA2736134A1 Lps based vaccines
03/11/2010CA2736091A1 2-oxo-1,2-dihydro-quinoline modulators of immune function
03/11/2010CA2735860A1 Synthetic methods and derivatives of triphosphate oligonucleotides
03/11/2010CA2735521A1 Indolizine inhibitors of leukotriene production
03/11/2010CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors
03/11/2010CA2734908A1 Compositions of pd-1 antagonists and methods of use
03/11/2010CA2733943A1 Peptides presenting an epitope of an a domain of factor h binding protein and methods of use
03/11/2010CA2733671A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
03/11/2010CA2733249A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/11/2010CA2732338A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen
03/10/2010EP2161338A1 Isolated mammalian monocyte cell genes; related reagents
03/10/2010EP2161329A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/10/2010EP2161275A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
03/10/2010EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof
03/10/2010EP2160409A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
03/10/2010EP2160393A1 Novel compounds as cannabinoid receptor ligands
03/10/2010EP1641474B1 Therapeutical composition containing dentritic cells and use thereof
03/10/2010EP1423376B1 Bicyclic compound, production and use thereof
03/10/2010EP1274833B1 A method to prevent graft rejection using tgf-beta to induce t suppressor cells
03/10/2010CN201418600Y Fresh and clean health-care pillow
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/09/2010US7674906 4-[4-(4-Amino-phenyl)-3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl]-benzoic acid methyl ester; rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis; CD80 antagonists capable of inhibiting the interactions between CD80 and CD28
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674830 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010CA2379282C Amido spiropiperidines promote the release of growth hormone
03/09/2010CA2172153C Regulation of bcl-2 gene expression
03/05/2010CA2654756A1 Vaccination for lawsonia intracellularis
03/04/2010WO2010025324A2 Nanoparticles for immunotherapy
03/04/2010WO2010025267A2 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
03/04/2010WO2010024956A2 Antihistamine and antihistamine-like nasal application, products, and method
03/04/2010WO2010024430A1 2,4-diaminopyrimidine compound
03/04/2010WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same
03/04/2010WO2010024298A1 Potassium channel regulator
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010WO2010024118A1 Novel recombinant protein having caspase recruitment domain applied thereto, and use thereof
03/04/2010WO2010022467A1 Immunomodulating activities
03/04/2010WO2009134428A3 Methods and compositions based on alk1 antagonists for modulating angiogenesis and pericyte coverage
03/04/2010WO2009126835A3 Magnetic nanoparticle and method for imaging t cells
03/04/2010WO2009023955A8 Cytotoxicity mediation of cells evidencing surface expression of cd9
03/04/2010US20100056641 Novel Aminoguanidines as Melanocortin Receptor Ligands
03/04/2010US20100056585 N-(2-Aminophenyl)-4-[N-(Pyridine-3-yl)-Methoxycarbonyl-Aminomethyl]-Benzamide (MS-275) Polymorph B
03/04/2010US20100056553 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
03/04/2010US20100056528 Sulfonamide derivatives with therapeutic indications
03/04/2010US20100056518 Cycloalkylamine substituted isoquinolone derivatives
03/04/2010US20100056507 Phenyl derivatives and their use as a medicament
03/04/2010US20100056495 Dimeric iap inhibitors
03/04/2010US20100056494 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases
03/04/2010US20100056488 Corticosteroid conjugates and uses thereof
03/04/2010US20100056480 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis
03/04/2010US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
03/04/2010US20100056448 Glut-1 as a receptor for htlv envelopes and its uses
03/04/2010US20100056447 Immunization against chlamydia pneumoniae
03/04/2010US20100056435 Depsipeptides and Their Therapeutic Use
03/04/2010US20100056434 Depsipeptides and Their Therapeutic Use
03/04/2010US20100055696 DRG11-Responsive (DRAGON) Gene Family
03/04/2010US20100055220 Skin external preparation in the form of water-in-oil emulsion comprising ceramide
03/04/2010US20100055166 Novel method and compositions
03/04/2010US20100055152 Antihistamine and antihistamine-like nasal application, products, and method
03/04/2010US20100055135 Enhancin of hepatitis b virus vaccine and its gene
03/04/2010US20100055131 Reovirus compositions and methods of use
03/04/2010US20100055130 Staphylococcus aureus proteins and nucleic acids
03/04/2010US20100055129 Modulators of myc, methods of using the same, and methods of indentifiying agents that modulate myc
03/04/2010US20100055127 Procedure For Expressing A Tbpb Protein On The Bacterial Surface Of An Attenuated Oral Live Vaccine As Prototype Of A Meningitis B Vaccine
03/04/2010US20100055125 Peptide Library
03/04/2010US20100055117 Allorestricted peptide-specific t cells
03/04/2010US20100055112 Enterococcus faecalis and/or Enterococcus faecium antigen
03/04/2010US20100055111 Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cells
03/04/2010US20100055103 Cross-reactive and bispecific anti-il-17a/f antibodies
03/04/2010US20100055091 Novel GL-50 Molecules and Uses Therefor
03/04/2010US20100055070 Cytokine-based fusion proteins for treatment of immune disorders
03/04/2010CA2738328A1 Immunomodulating activities
03/04/2010CA2735730A1 2,4-diaminopyrimidine compound
03/04/2010CA2735318A1 Nanoparticles for immunotherapy
03/04/2010CA2734390A1 Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
03/04/2010CA2732438A1 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
03/04/2010CA2730909A1 Method for treating multiple sclerosis patients with anti-il2r antibodies
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 1172